JBJoey V. Barnett

Joey V. Barnett

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joey V. Barnett has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Microvascular Function and Ambulatory Capacity in Peripheral Artery Disease

    by Alexander E. Sullivan, Adam Behroozian, Crystal Coolbaugh, Emily Shardelow, Emily K. Smith, Quinn S. Wells, Daniel G. Clair, Aaron W. Aday, C. Louis Garrard, John A. Curci, et al.

    BACKGROUND: Patients with peripheral artery disease experience walking impairment that is incompletely explained by large-artery atherosclerotic occlusive disease and abnormal ankle-brachial index (ABI). Microvascular dysfunction is associated with adverse outcomes, including amputation, but its effect on ambulation is unknown. We tested the hypothesis that skeletal muscle microvascular function directly associates with walking distance, is a more sensitive indicator of walking distance than conduit artery blood inflow, and correlates with ambulatory improvement following peripheral artery disease interventions. METHODS: Sixty-eight participants, including 50 with peripheral artery disease (ABI ≤0.85) and 18 healthy controls, underwent vascular function assessment after sphygmomanometer cuff-induced calf ischemia using magnetic resonance imaging measures of blood oxygenation level–dependent reactivity and arterial spin labeling perfusion reactivity. Functional status was assessed using the 6-minute walk test. A subgroup of patients with peripheral artery disease underwent repeat testing after supervised exercise therapy (n=14) or revascularization (n=14). Multivariable linear regression models were used to assess the association of macrovascular reactive hyperemic blood inflow within the conduit arteries, skeletal muscle microvascular blood oxygenation level–dependent reactivity, and walking distance. RESULTS: Resting large-artery pressure by ABI (R=0.74; P P P P =0.023). In those with repeat testing after intervention, the change in microvascular reactivity, but not ABI or macrovascular blood inflow, significantly correlated with the change in the 6-minute walk test distance (R=0.46; P =0.014). CONCLUSIONS: Microvascular reactivity after ischemia directly associates with walking distance and was a stronger predictor of walking distance than macrovascular blood inflow and ABI. After supervised exercise therapy or revascularization, improvements in microvascular function, but not macrovascular inflow or ABI, correlate with improvement in walking distance. Further study of microvascular dysfunction as a mechanistic driver of ambulatory function is warranted. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03490968.


  • Oxidative Stress Causes Mitochondrial and Electrophysiologic Dysfunction to Promote Atrial Fibrillation in Pitx2 +/− Mice

    by Tuerdi Subati, Kyungsoo Kim, Zhenjiang Yang, Matthew B. Murphy, Joseph C. Van Amburg, Isis L. Christopher, Owen P. Dougherty, Kaylen K. Woodall, Charles D. Smart, Joyce E. Johnson, et al.

    BACKGROUND: The strongest genetic risk factors for atrial fibrillation (AF) are DNA variants on chromosome 4q25 near the transcription factor gene PITX2 (Pitx2:Paired-like homeodomain transcription factor 2). Mice deficient in Pitx2 ( Pitx2 +/− ) have increased AF susceptibility, although the molecular mechanism(s) remains controversial. Pitx2 encodes a transcription factor that activates an antioxidant response to promote cardiac repair. Increased reactive oxygen species causing oxidation of polyunsaturated fatty acids generates reactive lipid dicarbonyl moieties that adduct to proteins and other macromolecules to promote cellular injury. We tested the hypothesis that oxidative stress, and specifically isolevuglandins, the most reactive lipid dicarbonyls identified, are increased in the setting of Pitx2 deficiency to promote proarrhythmic remodeling and AF. METHODS: Pitx2 +/− and Pitx2 +/+ wild-type littermate control mice were treated orally with vehicle, the lipid dicarbonyl scavenger 2-hydroxybenzylamine, or an inactive control compound at weaning, until study at age 16 to 18 weeks. RESULTS: Pitx2 +/− mice demonstrated increased P wave duration indicative of slowed atrial conduction, as well as increased inducible AF burden and sustained AF, compared with wild type, and these abnormalities were prevented by 2-hydroxybenzylamine. Both reactive oxygen species and isolevuglandin protein adducts were elevated in Pitx2 +/− atria with reduced expression of reactive oxygen species–protective genes. High-resolution respirometry demonstrated impaired mitochondrial function in Pitx2 +/− atria, with disruption of mitochondrial integrity and cell-cell junctions with connexin lateralization, as well as decreased mitochondrial biogenesis gene expression. Proarrhythmic ionic current remodeling in Pitx2 +/− atrial myocytes included elevated resting membrane potential, abbreviated action potential duration, and reduced maximum phase 0 upstroke velocity compared with wild type. Most of these abnormalities were ameliorated or prevented by 2-hydroxybenzylamine. CONCLUSIONS: These results demonstrate a critical role for lipid dicarbonyl mediators of oxidative stress in the proarrhythmic remodeling and AF susceptibility that occurs with Pitx2 deficiency, implying the possibility of genotype-specific therapy to prevent AF.


  • Open Access

    Innovations in Undergraduate Research Training Through Multisite Collaborative Programming: American Heart Association Summer Undergraduate Research Experience Syndicate

    by Tinuola B. Ajayi, Adrienne L. Mueller, Ike S. Okwuosa, Asha Barshilia, Joseph C. Wu, Emelia J. Benjamin, Joey V. Barnett, Kendra H. Oliver

    Background: To support diversity in biomedical science, the American Heart Association launched the Supporting Undergraduate Research Experiences for undergraduate students from underrepresented backgrounds to provide mentorship and high‐level exposure at 5 leading medical institutions. Here we describe the initial formation of the partnership and the alteration made in response to the program to accommodate COVID‐19 safety precautions. Methods and Results: We outline how programming shifted from local, in‐person programming in the summer of 2019 to a collaborative, mainly virtual curriculum in 2020 using students’ self‐reported before and after surveys from both 2019 (n=33) and 2020 (n=42). Students from both in‐person (2019) and virtual programs (2020) self‐reported significant gains in scientific proficiency. A qualitative‐directed content analysis of student open‐response questions was performed. Students reported extensive benefits from the 2020 virtual training, including Personal Gains, Research Skills, Thinking and Working Like a Scientist, and Attitudes and Behaviors. Notedly, we observed increases in the Attitudes and Behaviors category. We outline the pros and cons of in‐person and virtual programming and make recommendations moving forward in a postpandemic world with hybrid work and learning systems. Conclusions: Our effort informs the development of future undergraduate research training programs, significantly maximizing a hybrid training modality. The American Heart Association Supporting Undergraduate Research Experiences serves as a model for building multi‐institutional partnerships and providing research experiences that overcome institutional barriers and support students' interests, commitment, and ability to persist in science, technology, engineering, and math fields.


  • Natriuretic Peptide Oligomers Cause Proarrhythmic Metabolic and Electrophysiological Effects in Atrial Myocytes

    by Zhenjiang Yang, Tuerdi Subati, Kyungsoo Kim, Matthew B. Murphy, Owen P. Dougherty, Isis L. Christopher, Joseph C. Van Amburg, Kaylen K. Woodall, Joey V. Barnett, Katherine T. Murray

    Background: With aging, the human atrium invariably develops amyloid composed of ANP (atrial natriuretic peptide) and BNP (B-type natriuretic peptide). Preamyloid oligomers are the primary cytotoxic species in amyloidosis, and they accumulate in the atrium during human hypertension and a murine hypertensive model of atrial fibrillation susceptibility. We tested the hypothesis that preamyloid oligomers derived from natriuretic peptides cause cytotoxic and electrophysiological effects in atrial cells that promote arrhythmia susceptibility and that oligomer formation is enhanced for a mutant form of ANP linked to familial atrial fibrillation. Methods: Oligomerization was assessed by Western blot analysis. Bioenergic profiling was performed using the Seahorse platform. Mitochondrial dynamics were investigated with immunostaining and gene expression quantitated using quantitative reverse transcription polymerase chain reaction. Action potentials and ionic currents were recorded using patch-clamp methods and intracellular calcium measured using Fura-2. Results: Oligomer formation was markedly accelerated for mutant ANP (mutANP) compared with WT (wild type) ANP. Oligomers derived from ANP, BNP, and mutANP suppressed mitochondrial function in atrial HL-1 cardiomyocytes, associated with increased superoxide generation and reduced biogenesis, while monomers had no effects. In hypertensive mice, atrial cardiomyocytes displayed reduced action potential duration and maximal dV/dT of phase 0, with an elevated resting membrane potential, compared with normotensive mice. Similar changes were observed when atrial cells were exposed to oligomers. mutANP monomers produced similar electrophysiological effects as mutANP oligomers, likely due to accelerated oligomer formation, while ANP and BNP monomers did not. Oligomers decreased Na + current, inward rectifier K + current, and L-type Ca ++ current, while increasing sustained and transient outward K + currents, to account for these effects. Conclusions: These findings provide compelling evidence that natriuretic peptide oligomers are novel mediators of atrial arrhythmia susceptibility. Moreover, the accelerated oligomerization by mutANP supports a role for these mediators in the pathophysiology of this mutation in atrial fibrillation.


  • Optimizing transesophageal atrial pacing in mice to detect atrial fibrillation

    by Matthew B. Murphy, Kyungsoo Kim, Prince J. Kannankeril, Tuerdi Subati, Joseph C. Van Amburg, Joey V. Barnett, Katherine T. Murray

    Mice are routinely used to investigate molecular mechanisms underlying the atrial fibrillation (AF) substrate. We sought to optimize transesophageal rapid atrial pacing (RAP) protocols for the detection of AF susceptibility in mouse models. Hypertensive and control C57Bl/6J mice were subjected to burst RAP at a fixed stimulus amplitude. The role of parasympathetic involvement in pacing-related atrioventricular (AV) block and AF was examined using an intraperitoneal injection of atropine. In a crossover study, burst and decremental RAP at twice diastolic threshold were compared for induction of AV block during pacing. The efficacy of burst and decremental RAP to elicit an AF phenotype was subsequently investigated in mice deficient in the lymphocyte adaptor protein (Lnk−/−) resulting in systemic inflammation, or the paired-like homeodomain-2 transcription factor (Pitx2+/−) as a positive control. When pacing at a fixed stimulus intensity, pacing-induced AV block with AF induction occurred frequently, so that there was no difference in AF burden between hypertensive and control mice. These effects were prevented by atropine administration, implicating parasympathetic activation due to ganglionic stimulation as the etiology. When mice with AV block during pacing were eliminated from the analysis, male Lnk−/− mice displayed an AF phenotype only during burst RAP compared with controls, whereas male Pitx2+/− mice showed AF susceptibility during burst and decremental RAP. Notably, Lnk−/− and Pitx2+/− females exhibited no AF phenotype. Our data support the conclusion that multiple parameters should be used to ascertain AF inducibility and facilitate reproducibility across models and studies. NEW & NOTEWORTHY Methods were developed to optimize transesophageal rapid atrial pacing (RAP) to detect AF susceptibility in new and established mouse models. High stimulus intensity and pacing rates caused parasympathetic stimulation, with pacing-induced AV block and excessive AF induction in normal mice. For a given model, pacing at twice TH enabled improved phenotype discrimination in a pacing mode and sex-specific manner. Transesophageal RAP should be individually optimized when developing a mouse model of AF.


  • Open Access

    Transforming Growth Factor‐β stimulates smooth muscle differentiation in epicardial cells lacking the Type III Receptor

    by Joey V. Barnett, Leigh A. Compton, Joey D. Love, Anita F. Austin

    Transforming growth factor (TGF) β receptor III (TGFβR3) binds all 3 TGFβ ligands and inhibin with high affinity but lacks the serine/threonine kinase domain found in the type I and type II receptors (TGFβR1, TGFβR2). TGFβR3 facilitates signaling via TGFβR1/TGFβR2 but also has been suggested to play a unique and nonredundant role in TGFβ signaling. Coronary vessel development is impaired in Tgfbr3 null mice with few vessels formed and mice die at embryonic day (E) 14.5. In null mice, vessels throughout the yolk sac and embryo form and recruit smooth muscle in a pattern indistinguishable from heterozygous or wild‐type littermates. Null mice form 2 coronary ostia and appear to initiate smooth muscle recruitment by E14. To directly address the role of Tgfbr3 in smooth muscle differentiation in epicardial cells we generated immortalized cell lines from wildtype, heterozygous null, and null animals at E11.5 and E13.5. Cells from all genotypes grew as tightly packed epithelium and expressed Zonula Occludens‐1 (ZO‐1). The addition of 250 pM TGFβ1 or TGFβ2 demonstrated a loss of epithelial morphology as measured by the loss of ZO‐1. TGFβ1 or TGFβ2 induced the smooth muscle marker SM22α in all genotypes. Therefore, TGFβR3 is not required in epicardial cells for smooth muscle differentiation and the defect in coronary vessel development seen in Tgfbr3 null mice is likely not due to defects in smooth muscle recruitment.